findmyKOL
Clinical trialNCT01875653TerminatedPhase 3Interventional

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

SponsorLisata Therapeutics, Inc.Enrollment4Stage III MelanomaStage IV Melanoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Irvine, California, United States

  • Facility name not stated

    La Jolla, California, United States

  • Facility name not stated

    Los Angeles, California, United States

  • Facility name not stated

    Newport Beach, California, United States

  • Facility name not stated

    Orange, California, United States

  • Facility name not stated

    Santa Monica, California, United States

  • Facility name not stated

    Aurora, Colorado, United States

  • Facility name not stated

    Goshen, Indiana, United States

  • Facility name not stated

    Louisville, Kentucky, United States

  • Facility name not stated

    Marrero, Louisiana, United States

  • Facility name not stated

    Baltimore, Maryland, United States

  • Facility name not stated

    Hackensack, New Jersey, United States

  • Facility name not stated

    Cincinnati, Ohio, United States

  • Facility name not stated

    Easton, Pennsylvania, United States

  • Facility name not stated

    Philadelphia, Pennsylvania, United States

  • Facility name not stated

    Philadelphia, Pennsylvania, United States

  • Facility name not stated

    Knoxville, Tennessee, United States

  • Facility name not stated

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2014
Primary completion
31 Jan 2016
Completion
31 Jan 2016
Last update posted
10 May 2019
Registered enrollment
4
Registry id
NCT01875653

Cross-registrations

EU-CTR / CTIS (EudraCT)2015-001984-38

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.